When drugmakers pulled the weight-loss drug fen-phen off the market in 1997, my mom was devastated. Not because the FDA ...

Cool wholesale inflation numbers provide only slight relief before Wednesday's release of December Consumer Price Index data.

Up to 3.4 million eligible patients could benefit from the medication that treats type 2 diabetes and aids weight loss ...

Doctors have long told how they are treating increasing numbers of Brits who end up in hospital after providing false ...

Can this diabetes-control breakthrough also become the answer to obesity? From Hollywood’s red carpets to affluent Indians, ...

As we embark on 2025, the health care industry, providers and patients should be prepared for a lot of innovation, and not a ...

Weight-loss injection Mounjaro, also known as tirzepatide, will be rolled out on the NHS gradually over a 12-year period, starting this year, but many eligible patients will have to wait.

To accomplish these goals, it's fair to assume that some people will ultimately turn to weight-loss drugs such as Ozempic and ...

But for now, if you’re wondering what the playoff picture looks like, you’ve come to the right place. A few teams have already been eliminated (sorry to your squad if you root for them ...

Eli Lilly, a leading US pharmaceutical company, is gearing up to launch its groundbreaking diabetes and obesity medication, Tirzepatide—commercially known as Mounjaro—in India by 2025.

The posts, shared on X, also saw AI-generated images of Musk and some users discussing the Ozempic reference. Elon Musk's 'Ozempic Santa' look (Picture credit: X) In the picture, Musk is standing ...